Scantox Neuro Gmbh
CAGE Code: 3613N
NCAGE Code: 3613N
Status: Active
Type: Commercial Supplier
Summary
Scantox Neuro Gmbh is an Active Commercial Supplier with the Cage Code 3613N.
Address
Parkring 12
Grambach
Steiermark
8074
Austria
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
North Power Construction Company Newyork Eagle Construction Company Super Jet Group Sina Aria Logistic And Trading Arif Noor Construction Company,Ltd Melad Abrar Intl. Transit And Bashir Qayum Logistics Services Dostamani Construction Company Sayed Zawar Ali Khan Renewable Energy Agency Jlcc Mohammad Eisa Sardarzada Well Naweed Insaaf Construction Company Aria Roshan Trading Company Inc Abdul Waris Kamran Road And Priority Development Stratigic Co Ace Limited Liability Company Asct Group Seroosh Services Lux Star Construction Company
Frequently Asked Questions (FAQ) for CAGE 3613N
- What is CAGE Code 3613N?
- 3613N is the unique identifier used by NATO Organizations to reference the physical entity known as Scantox Neuro Gmbh located at Parkring 12, Grambach, Steiermark, 8074, Austria.
- Who is CAGE Code 3613N?
- 3613N refers to Scantox Neuro Gmbh located at Parkring 12, Grambach, Steiermark, 8074, Austria.
- Where is CAGE Code 3613N Located?
- CAGE Code 3613N is located in Grambach, Austria.
Contracting History for CAGE 3613N Most Recent 25 Records
- 75N95023P00617
- Pharmacodynamic And Tolerability Studies Of Candidate Ad Drugs In A Transgenic Ad Mouse Model
- 29 Aug 2023
- Pharmacodynamic And Tolerability Studies Of Candidate Ad Drugs In A Transgenic Ad Mouse Model
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $249,334.00
- Department Of Health And Human Services (Hhs)
- 75N95022P00542
- Tolerability Studies Of Candidate Ad Drugs And Efficacy Of Poly(L-Lysine Succinylated)-Hydroxychloroquine (Pls-Hcq) In A Transgenic Ad Mouse Model
- 12 Sep 2022
- Tolerability Studies Of Candidate Ad Drugs And Efficacy Of Poly(L-Lysine Succinylated)-Hydroxychloroquine (Pls-Hcq) In A Transgenic Ad Mouse Model
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $249,000.00
- Department Of Health And Human Services (Hhs)
- 75N95022D00012
- Experimental Validation Of Candidate Alzheimer's Disease Treatments Identified By Multi-Omics Analyses
- 30 Nov 2022
- Experimental Validation Of Candidate Alzheimer's Disease Treatments Identified By Multi-Omics Analyses
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $0.00
- Department Of Health And Human Services (Hhs)
- 75N95022D00012
- Experimental Validation Of Candidate Alzheimer's Disease Treatments Identified By Multi-Omics Analyses
- 31 May 2022
- Experimental Validation Of Candidate Alzheimer's Disease Treatments Identified By Multi-Omics Analyses
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $0.00
- Department Of Health And Human Services (Hhs)
- 75N95023F00001
- Experimental Validation Of Candidate Alzheimer's Disease Treatments Identified By Multi-Omics Analyses
- 15 May 2023
- Experimental Validation Of Candidate Alzheimer's Disease Treatments Identified By Multi-Omics Analyses
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $821,359.00
- Department Of Health And Human Services (Hhs)
- 75N95021P00466
- In Vivo Efficacy Studies Of A Candidate Alzheimer Treatment In A Transgenic Mouse Model
- 4 Jan 2022
- In Vivo Efficacy Studies Of A Candidate Alzheimer Treatment In A Transgenic Mouse Model
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $199,812.00
- Department Of Health And Human Services (Hhs)
- 75N95020P00696
- Phenotypic Screening Of Candidate Drugs To Treat Alzheimers Disease.
- 11 Aug 2021
- Phenotypic Screening Of Candidate Drugs To Treat Alzheimers Disease.
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $298,624.00
- Department Of Health And Human Services (Hhs)
- 75N95020P00696
- Phenotypic Screening Of Candidate Drugs To Treat Alzheimers Disease
- 30 Nov 2022
- Phenotypic Screening Of Candidate Drugs To Treat Alzheimers Disease
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $298,624.00
- Department Of Health And Human Services (Hhs)
- 75N95021P00466
- In Vivo Efficacy Studies Of A Candidate Alzheimer Treatment In A Transgenic Mouse Model
- 10 Sep 2021
- In Vivo Efficacy Studies Of A Candidate Alzheimer Treatment In A Transgenic Mouse Model
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $186,198.00
- Department Of Health And Human Services (Hhs)
- 75N95022F00001
- Experimental Validation Of Candidate Alzheimer's Disease Treatments Identified By Multi-Omics Analyses
- 1 Jun 2022
- Experimental Validation Of Candidate Alzheimer's Disease Treatments Identified By Multi-Omics Analyses
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $638,000.00
- Department Of Health And Human Services (Hhs)